unknown
Stage
2012
Founded
2
Investors
About
Acousia develops novel small molecule therapeutics to enhance and preserve natural hearing in patients with sensorineural hearing loss (SNHL), addressing a major unmet medical need.
Explore Acousia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.